Curcumin
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
933 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 5 | 11 | 9 | 3 | 8 | 31 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 5 | 7 | 6 | 1 | 10 | 25 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 9 | 2 | 7 | 1 | 1 | 19 |
| Syndrome | D013577 | — | — | 2 | 4 | 1 | 1 | 11 | 18 |
| Hepatitis c | D006526 | — | B19.2 | 8 | 8 | 1 | 2 | — | 18 |
| Hepatitis | D006505 | — | K75.9 | 9 | 3 | 1 | 4 | 1 | 17 |
| Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | 3 | 3 | 2 | 4 | 2 | 14 |
| Hepatitis a | D006506 | EFO_0007305 | B15 | 7 | 2 | 1 | 4 | 1 | 14 |
| Postpartum hemorrhage | D006473 | — | O72 | — | 1 | 2 | 4 | 8 | 14 |
| Infections | D007239 | EFO_0000544 | — | 1 | 3 | 2 | 3 | 3 | 12 |
Show 72 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 7 | 14 | 5 | — | 8 | 32 |
| Neoplasms | D009369 | — | C80 | 19 | 10 | 2 | — | 3 | 31 |
| Inflammation | D007249 | MP_0001845 | — | 2 | 3 | 2 | — | 21 | 27 |
| Prostatic neoplasms | D011471 | — | C61 | 5 | 7 | 2 | — | 4 | 17 |
| Covid-19 | D000086382 | — | U07.1 | — | 3 | 6 | — | 9 | 16 |
| Colorectal neoplasms | D015179 | — | — | 7 | 6 | 2 | — | 2 | 15 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | 5 | 4 | — | 5 | 14 |
| Lymphoma | D008223 | — | C85.9 | 6 | 9 | 1 | — | — | 14 |
| Cognitive dysfunction | D060825 | — | G31.84 | 2 | 5 | 1 | — | 7 | 14 |
| Chronic renal insufficiency | D051436 | — | N18 | 2 | 4 | 4 | — | 4 | 13 |
Show 134 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 48 | 3 | — | — | 21 | 71 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 2 | 4 | — | — | 7 | 12 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 3 | 2 | — | — | 5 | 10 |
| Asthma | D001249 | EFO_0000270 | J45 | 2 | 4 | — | — | 2 | 8 |
| Head and neck neoplasms | D006258 | — | — | 2 | 2 | — | — | 3 | 7 |
| Lung diseases | D008171 | EFO_0003818 | J98.4 | 1 | 3 | — | — | 3 | 7 |
| Inflammatory bowel diseases | D015212 | EFO_0003767 | — | 1 | 1 | — | — | 5 | 7 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 5 | 3 | — | — | — | 6 |
| Non-small-cell lung carcinoma | D002289 | — | — | 5 | 3 | — | — | — | 6 |
| Obstructive lung diseases | D008173 | — | — | — | 2 | — | — | 4 | 6 |
Show 164 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Overweight | D050177 | — | E66.3 | 2 | — | — | — | 4 | 6 |
| Dementia | D003704 | EFO_0003862 | F03 | 1 | — | — | — | 3 | 4 |
| Bacterial infections | D001424 | — | A49 | 3 | — | — | — | 1 | 4 |
| Autistic disorder | D001321 | EFO_0003758 | F84.0 | 1 | — | — | — | 3 | 4 |
| Autism spectrum disorder | D000067877 | — | F84.0 | 1 | — | — | — | 3 | 4 |
| Pharmacokinetics | D010599 | — | — | 2 | — | — | — | 1 | 3 |
| Central nervous system neoplasms | D016543 | — | — | 1 | — | — | — | 2 | 3 |
| Carcinoma in situ | D002278 | — | D09.9 | 2 | — | — | — | 1 | 3 |
| Vaping | D000072137 | — | — | 1 | — | — | — | 2 | 3 |
| Hiv-1 | D015497 | — | — | 2 | — | — | — | — | 2 |
Show 64 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | — | — | 6 | 6 |
| Iron deficiencies | D000090463 | — | E61.1 | — | — | — | — | 5 | 5 |
| Iron-deficiency anemia | D018798 | — | D50 | — | — | — | — | 4 | 4 |
| Healthy diet | D000072001 | — | — | — | — | — | — | 3 | 3 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | — | — | — | 3 | 3 |
| Adenoma | D000236 | — | — | — | — | — | — | 2 | 2 |
| Cardiomyopathies | D009202 | EFO_0000318 | I42 | — | — | — | — | 2 | 2 |
| Pneumonia | D011014 | EFO_0003106 | J18 | — | — | — | — | 2 | 2 |
| Phenylketonurias | D010661 | — | E70.0 | — | — | — | — | 2 | 2 |
| Male infertility | D007248 | EFO_0004248 | N46 | — | — | — | — | 2 | 2 |
Show 224 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
2,842 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use